SCHEMBL3732157

SCHEMBL3732157

COC(=O)CCc1ccc(N)c(C(=O)N(C)C)c1

nearest known ligand 0.49

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.49
GAA P10253 2/20 0.49
KDM4E B2RXH2 1/20 0.49
MAPT P10636 1/20 0.49
HPGD P15428 1/20 0.49
ALOX15 P16050 1/20 0.49
TSHR P16473 1/20 0.49
HSD17B10 Q99714 1/20 0.49
SIRT2 Q8IXJ6 1/20 0.43
GFER P55789 1/20 0.41
HDAC1 Q13547 1/20 0.41
MAP4K1 Q92918 8/20 0.40
CYP3A4 P08684 2/20 0.40
KCNH2 Q12809 1/20 0.40
ABL1 P00519 1/20 0.40
CDC25B P30305 1/20 0.40
CASP6 P55212 1/20 0.40
RCE1 Q9Y256 1/20 0.40
PTPN1 P18031 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL400213 0.86 CYP4F2 (0.51) ALDH1A1GAAKDM4EMAPTHPGD
SCHEMBL10174593 0.86 KCNH2 (0.42) SIRT2KCNH2PTPN1
SCHEMBL3732606 0.86 ALDH1A1 (0.57) ALDH1A1GAAKDM4EMAPTHPGD
SCHEMBL2323612 0.84 ALDH1A1 (0.53) ALDH1A1GAAKDM4EMAPTHPGD
SCHEMBL18046156 0.81 ALDH1A1 (0.53) ALDH1A1GAAKDM4EMAPTHPGD
SCHEMBL3680541 0.80 ALDH1A1 (0.45) ALDH1A1GAAKDM4EMAPTHPGD
SCHEMBL8233730 0.80 ALDH1A1 (0.45) ALDH1A1GAAKDM4EMAPTHPGD
SCHEMBL23582361 0.78 GAA (0.54) ALDH1A1GAAKDM4EMAPTHPGD
SCHEMBL7283109 0.77 ALDH1A1 (0.57) ALDH1A1GAAMAPTTSHRHSD17B10
SCHEMBL23665899 0.77 CYP3A4 (0.49) ALDH1A1GAAKDM4EMAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100158996-A1 ESTER COMPOUND AND MEDICAL USE THEREOF JAPAN TOBACCO INC. 2010-06-24 US disclosed
US-20100158996-A1 ESTER COMPOUND AND MEDICAL USE THEREOF JAPAN TOBACCO INC. 2010-06-24 US disclosed
US-20100158996-A1 ESTER COMPOUND AND MEDICAL USE THEREOF JAPAN TOBACCO INC. 2010-06-24 US disclosed
US-7625948-B2 Ester compound and medicinal use thereof JAPAN TOBACCO INC. (JP) 2009-12-01 US disclosed
US-7625948-B2 Ester compound and medicinal use thereof JAPAN TOBACCO INC. (JP) 2009-12-01 US disclosed
US-7625948-B2 Ester compound and medicinal use thereof JAPAN TOBACCO INC. (JP) 2009-12-01 US disclosed
US-20050075367-A1 Ester compound and medicinal use thereof JAPAN TOBACCO INC. (JP) 2005-04-07 US disclosed
EP-1479666-A1 ESTER COMPOUND AND MEDICINAL USE THEREOF JAPAN TOBACCO INC. (JP) 2004-11-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050075367-A1 Ester compound and medicinal use thereof LIPC, CES1, MTTP ALDH1A1 564/4885GAA 2055/4885KDM4E 2265/4885
US-20100158996-A1 ESTER COMPOUND AND MEDICAL USE THEREOF LIPC, CES1, MTTP ALDH1A1 603/4885GAA 1962/4885KDM4E 2442/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.